How a rare-disease clinical program may illuminate aging biology and influence a company's long-term therapeutic strategy.
Key Takeaways
- Calico Life Sciences has received US FDA Breakthrough Therapy Designation for fosigotifator
- Breakthrough Therapy Designation is unquestionably significant in its own right
- These are the hallmarks of the aged cell